CYTK Has Cash, Revenue, and a Catalyst. Does That Clear the Bar?
Aficamten's ACACIA win removes the binary risk that has kept a lid on the stock. Here is how the risk-reward…
Aficamten's ACACIA win removes the binary risk that has kept a lid on the stock. Here is how the risk-reward…
The benchmark revision resets every assumption entering the most consequential data week of the year.
A court just ruled that supply-chain risk labels can be weaponized as retaliation. The buy side should rethink how it…
CACI and Gartner are surging for different reasons. Both have durable compounding math.
Google’s $10 million Spirit buy is a preview of how AI labs may feed themselves when clean data runs out.
The China distribution reset mirrors the DTC pivot that hurt Nike in North America.
An Iranian adviser signaled the Hormuz standoff may last into 2029. Marathon Petroleum just posted $17.73 in adjusted EPS. The…
A revenue miss still sent SMCI up about 10%. Gross margin rising to about 17% is rewriting the investment case.
The CBO's August update just raised the debt-service alarm. The 30-year auction Thursday is where the real stress test begins.
The Hassabis shift and the Dean exit are symptoms. The chip allocation fight is the disease.